Good Ventures, the foundation that supports the Open Philanthropy Project, has made a series of grants to psychedelic research organizations:
- Feb 2019 to the Usona Institute (a)
- Aug 2018 to MAPS (a)
- Feb 2018 to the Usona Institute (a)
- Aug 2017 to MAPS (a)
- Sept 2016 to the Heffter Research Institute (a)
- Dec 2015 to the Heffter Research Institute (a)
These grants are relatively small compared to the foundation's overall grantmaking capacity, but seem to indicate that Good Ventures has a clear & consistent interest in supporting psychedelic research.
There isn't any record of these grants on the Open Phil site.
Seems like these grants could be neatly housed under Open Phil's "Scientific Research" cause area, perhaps in the "Other Scientific Research" portfolio.
I'm curious about why there's a separation between Good Ventures' psychedelic grantmaking & the grants it makes through Open Phil.
(It's possible that this is simply an oversight, though given what I know about Open Phil's processes I'm guessing it's an intentional separation.)
As an aside, I wouldn't say that any Good Ventures things are 'housed under Open Phil'. I'd rather say that Open Phil makes recommendations to Good Ventures. i.e. Open Phil is a partner to Good Ventures, not a subsidiary.
Technically, I've therefore answered a different question to the one you asked: I've answered the question 'why aren't these grants on the Open Phil website'.
There's an unanswered question here of why Good Ventures makes grants that OpenPhil doesn't recommend, given that GV believes in the OpenPhil approach broadly. But I guess I don't find it that surprising that they do so. People like to do more than one thing?
Thanks!
I just flipped through the Good Ventures grants database & spot-checked ~30 of their 2018 grants.
Every grant I checked was made under the aegis of Open Phil, except for the aforementioned psychedelic grants & these grants to Alzheimer's research: 1, 2, 3, 4
The same question comes up for the Alzheimer's grants – seems like they could be neatly placed in Open Phil's other scientific research portfolio, but weren't.